CIK 0000944809 · Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 752402409
- Phone
- 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,577
- in 1 filing
Net −$24,577. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-19 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +500,000 | $0.98 | $489K | 205,868,225 |
| 2024-01-18 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +400,000 | $0.97 | $386K | 205,368,225 |
| 2024-01-17 | HSIAO JANE PH D Vice Chairman & CTO | Purchase | +150,000 | $0.95 | $143K | 27,999,880 |
| 2024-01-16 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +1,000,000 | $0.95 | $954K | 204,968,225 |
| 2024-01-11 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +511,531 | $0.94 | $480K | 203,968,225 |
| 2024-01-08 | Nabel Gary J. Chief Innovation Officer | Purchase | +108,695 | $0.93 | $101K | 351,442 |
| 2024-01-08 | Nabel Gary J. Chief Innovation Officer | Purchase | +500 | $0.92 | $459 | 500 |
| 2024-01-08 | Nabel Gary J. Chief Innovation Officer | Purchase | +106,989 | $0.93 | $99K | 107,489 |
| 2024-01-05 | HSIAO JANE PH D Vice Chairman & CTO | Purchase | +150,010 | $0.87 | $131K | 27,849,880 |
| 2024-01-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +1,500,000 | $0.90 | $1.3M | 203,456,694 |
| 2024-01-05 | Zerhouni Elias A. Vice Chairman and President | Purchase | +17,000 | $0.87 | $15K | 19,794,514 |
| 2024-01-05 | Zerhouni Elias A. Vice Chairman and President | Purchase | +33,300 | $0.91 | $30K | 19,827,814 |
| 2024-01-05 | Zerhouni Elias A. Vice Chairman and President | Purchase | +100,000 | $0.93 | $93K | 19,927,814 |
| 2024-01-05 | Zerhouni Elias A. Vice Chairman and President | Purchase | +400,000 | $0.94 | $376K | 20,327,814 |
| 2024-01-05 | PAGANELLI JOHN A Director | Purchase | +25,000 | $0.88 | $22K | 384,340 |
| 2024-01-05 | Rubin Steven D Executive VP-Administration | Purchase | +10,000 | $0.87 | $9K | 6,187,732 |
| 2024-01-05 | PFENNIGER RICHARD C JR Director | Purchase | +13,000 | $0.93 | $12K | 313,000 |
| 2024-01-05 | PFENNIGER RICHARD C JR Director | Purchase | +12,000 | $0.95 | $11K | 325,000 |
| 2024-01-04 | HSIAO JANE PH D Vice Chairman & CTO | Returned to the company · 5% Convertible Notes due 2025 | −0 | |||
| 2024-01-04 | HSIAO JANE PH D Vice Chairman & CTO | Grant or award · 3.75% Convertible Notes due 2029 | +0 |
Page 6 of 8 · 159 trades